Login to Your Account



Psioxus to Elicit Immunological Response of Oncolytic Vaccine

By Nuala Moran
Staff Writer

Tuesday, June 25, 2013
LONDON – While oncolytic cancer vaccines are advancing in the clinic, there is as yet limited understanding of how they exert their effects on the immune system after infected tumor cells burst. That process releases more virus to infect and lyse more tumor cells, but it also discharges inflammatory mediators and cell-specific tumor antigens that prompt the immune system to react against the tumor.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription